| CEOS Stock | | | USD 0.01 0.0001 1.64% |
Chairman
Mr. James J. Fiedler is President and Chief Executive Officer of the company, and elected to the Board of Directors and became its Chairman. Mr. Fiedler is an experienced executive in the consulting, computer, defense systems, enterprise software, wired and wireless telecommunications and cable television industries. He has extensive experience in fund raising, initial public offerings and mergers and acquisitions. Since April 2000, Mr. Fiedler was a partner at Johnson Fiedler Associates, a firm whose activities consist of valuation, due diligence, strategic plan review and mergers and acquisitions reviews of technology companies for consulting firms, fund managers and investment banks. From June 2007 to July 2008, Mr. Fiedler was the Chairman and Chief Executive Officer of Athena Technology Inc., an electronic switching equipment designer and manufacturer, and Chairman and President of Athena Technology LLC, a telecom software developer. Previously, his experience included being the Chief Operating Officer of Timeplex, Inc., a subsidiary of Unisys Corporation from July 1989 to August 1992, President and Chief Executive Officer of Summa Four Inc. from November 1992 to August 1994, and Chairman and Chief Executive Officer of Coyote Network Systems, Inc. from October 1996 to April 2000 since 2008.
| Age | 76 |
| Tenure | 17 years |
| Phone | 888 376 8258 |
| Web | https://www.psykeyworld.com |
Fiedler graduated from Kent State University in Ohio, earning a B.S. degree in math and B.A. degree in physics.
CeCors Management Efficiency
The company has return on total asset
(ROA) of
(1.7972) % which means that it has lost $1.7972 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity
(ROE) of
(7.261) %, meaning that it created substantial loss on money invested by shareholders. CeCors' management efficiency ratios could be used to measure how well CeCors manages its routine affairs as well as how well it operates its assets and liabilities.
CeCors Inc currently holds 956.88
K in liabilities. CeCors Inc has a current ratio of 0.32, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist CeCors until it has trouble settling it off, either with new capital or with free cash flow. So, CeCors' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CeCors Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CeCors to invest in growth at high rates of return. When we think about CeCors' use of debt, we should always consider it together with cash and equity.
Similar Executives
Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. Psykey, Inc. was founded in 2002 and is based in Toronto, Canada. CECORS INC operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 6 people. CeCors Inc [CEOS] is a
Pink Sheet which is traded between brokers over the counter.
Management Performance
CeCors Inc Leadership Team
Elected by the shareholders, the CeCors' board of directors comprises two types of representatives: CeCors inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CeCors. The board's role is to monitor CeCors' management team and ensure that shareholders' interests are well served. CeCors' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CeCors' outside directors are responsible for providing unbiased perspectives on the board's policies.
CeCors Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is CeCors a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for CeCors Pink Sheet Analysis
When running CeCors' price analysis, check to
measure CeCors' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CeCors is operating at the current time. Most of CeCors' value examination focuses on studying past and present price action to
predict the probability of CeCors' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CeCors' price. Additionally, you may evaluate how the addition of CeCors to your portfolios can decrease your overall portfolio volatility.